Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free LYRA Stock Alerts

Lyra Therapeutics (LYRA) Short Interest Ratio & Short Volume

Lyra Therapeutics logo
$0.80 +0.10 (+14.29%)
As of 06/9/2026 03:04 PM Eastern
Compare

Lyra Therapeutics Short Interest Overview

As of March 13, 2026, Lyra Therapeutics (LYRA) had a short interest of 42,622 shares sold short, representing 2.48% of the public float. This marks a 157.80% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.5, meaning it would take 0.5 days of the average trading volume of 61,224 shares to cover all short positions.

Current Short Interest
42,622 shares
Previous Short Interest
16,533 shares
Change Vs. Previous Month
157.80%
Dollar Volume Sold Short
$56.26 thousand
Short Interest Ratio
0.5 Days to Cover
Last Record Date
March 13, 2026
Outstanding Shares
1,775,000 shares
Short Percent of Float
2.48%
Today's Trading Volume
2,058 shares
Average Trading Volume
61,224 shares
Today's Volume Vs. Average
3%
Short Selling Lyra Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lyra Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

LYRA Short Interest Over Time

LYRA Days to Cover Over Time

LYRA Percentage of Float Shorted Over Time

Lyra Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/13/202642,622 shares $56.26 thousand +157.8%2.5%0.47 $1.32
2/27/202616,533 shares $16.70 thousand -70.7%1.0%0.49 $1.01
2/13/202656,490 shares $78.52 thousand -4.4%3.3%1.31 $1.39
1/30/202659,094 shares $105.19 thousand +54.1%3.4%0.6 $1.78
1/15/202638,347 shares $74.58 thousand +2.4%2.2%0.22 $1.95
12/31/202537,456 shares $115.36 thousand -31.8%2.2%1.45 $3.08
12/15/202554,931 shares $215.88 thousand +3.3%3.2%1.22 $3.93
11/28/202553,195 shares $188.58 thousand +14.4%3.1%0.35 $3.55
11/14/202546,498 shares $179.02 thousand +98.9%2.7%1.12 $3.85
10/31/202523,373 shares $135.31 thousand -38.4%1.5%1.19 $5.79
10/15/202537,900 shares $285.01 thousand +54.1%2.4%1.3 $7.52
9/30/202524,600 shares $160.64 thousand -19.6%N/A0.8 $6.53
9/15/202530,600 shares $192.17 thousand -32.9%N/A0.7 $6.28
8/31/202545,600 shares $319.20 thousand -9.7%2.9%0.5 $7.00
8/15/202550,500 shares $356.03 thousand +10.8%N/A0.1 $7.05
7/31/202545,600 shares $305.52 thousand -8.6%2.9%0.1 $6.70
7/15/202549,900 shares $423.15 thousand -59.7%N/A0.1 $8.48
6/30/2025123,900 shares $1.11 million +8.9%7.7%0.2 $8.96
6/15/2025113,800 shares $1.29 million +37.9%8.6%0.2 $11.34
5/31/202582,500 shares $386.10 thousand -43.7%7.4%0.1 $4.68
5/15/2025146,600 shares $16.54 thousand -94.6%13.1%2.3 $0.11
4/30/20252,700,000 shares $320.76 thousand +21.6%N/A1.5 $0.12
4/15/20252,220,000 shares $204.68 thousand -7.9%3.6%1.9 $0.09
3/31/20252,410,000 shares $304.38 thousand +0.4%3.9%2.2 $0.13
3/15/20252,400,000 shares $412.80 thousand +27.7%3.8%2 $0.17
2/28/20251,880,000 shares $402.32 thousand -13.4%3.0%1.5 $0.21
2/15/20252,170,000 shares $451.79 thousand +1.4%3.5%1.5 $0.21
1/31/20252,140,000 shares $391.19 thousand +0.5%N/A1.2 $0.18
1/15/20252,130,000 shares $402.57 thousand +1.4%N/A1.1 $0.19
12/31/20242,100,000 shares $433.44 thousand +14.1%N/A1.1 $0.21
12/15/20241,840,000 shares $335.98 thousand -16.4%N/A1.1 $0.18
11/30/20242,200,000 shares $455.40 thousand -7.6%N/A1.4 $0.21
11/15/20242,380,000 shares $404.60 thousand +16.7%N/A1.6 $0.17
10/31/20242,040,000 shares $560.80 thousand -4.7%N/A2.1 $0.27
10/15/20242,140,000 shares $488.78 thousand -24.9%N/A2.2 $0.23
9/30/20242,850,000 shares $732.45 thousand -9.2%N/A3.2 $0.26
9/15/20243,140,000 shares $879.20 thousand +6.1%N/A2.7 $0.28
8/31/20242,960,000 shares $952.23 thousand -28.7%N/A2.3 $0.32
8/15/20244,150,000 shares $1.20 million +18.6%N/A2.7 $0.29
7/31/20243,500,000 shares $1.14 million -5.9%N/A1.7 $0.33
80X Growth in ONE Quarter (Read before June 16) (Ad)

Marc Chaikin - creator of one of Wall Street's most widely used indicators - is sounding the alarm on a pre-IPO AI lab that saw revenue surge 80-fold in a single quarter, putting it on pace to outsell OpenAI and SpaceX combined. The company, now valued at $965 billion, is expected to debut publicly this fall. But Chaikin believes a June 16 announcement tied to its internal 'Project Tengu' could push that valuation significantly higher - and he's identified a $40 backdoor play available right now.tc pixel

Get the full details on this AI IPO opportunity before June 16
7/15/20243,720,000 shares $1.13 million +86.9%N/A1 $0.31
6/30/20241,990,000 shares $550.63 thousand +28.4%N/A0.5 $0.28
6/15/20241,550,000 shares $457.56 thousand +71.8%N/A0.4 $0.30
5/31/2024902,200 shares $295.92 thousand +49.6%N/A0.3 $0.33
5/15/2024603,000 shares $214.55 thousand +45.7%N/A0.2 $0.36
4/30/2024413,800 shares $2.14 million +24.0%N/A0.2 $5.16
4/15/2024333,600 shares $1.76 million +49.6%N/A1 $5.27
3/31/2024223,000 shares $1.39 million +8.1%N/A0.7 $6.22
3/15/2024206,300 shares $1.22 million +28.8%N/A0.8 $5.93
2/29/2024160,200 shares $842.65 thousand -13.6%N/A0.6 $5.26
2/15/2024185,400 shares $927 thousand +43.5%N/A0.8 $5.00
1/31/2024129,200 shares $587.86 thousand -5.6%N/A0.6 $4.55
1/15/2024136,900 shares $736.52 thousand -22.6%N/A0.6 $5.38
12/31/2023176,800 shares $926.43 thousand +2.4%N/A0.9 $5.24
12/15/2023172,600 shares $802.59 thousand -24.4%N/A0.7 $4.65
11/30/2023228,300 shares $755.67 thousand -13.9%N/A0.6 $3.31
11/15/2023265,200 shares $766.43 thousand -17.3%N/A0.7 $2.89
10/31/2023320,600 shares $952.18 thousand +43.2%N/A0.9 $2.97
10/15/2023223,900 shares $801.56 thousand -38.2%N/A0.6 $3.58
9/30/2023362,100 shares $1.42 million -14.0%N/A0.9 $3.91
9/15/2023421,100 shares $1.83 million +661.5%N/A1.2 $4.35
8/31/202355,300 shares $192.44 thousand -19.5%N/A0.3 $3.48
8/15/202368,700 shares $245.95 thousand -67.0%N/A0.4 $3.58
7/31/2023208,100 shares $670.08 thousand -62.3%N/A1.1 $3.22
7/15/2023552,200 shares $1.69 million -0.1%N/A3.4 $3.06
6/30/2023552,600 shares $2.27 million +23.4%N/A4.2 $4.11
6/15/2023447,700 shares $1.34 million +56.8%N/A3.9 $2.99
5/31/2023285,500 shares $733.74 thousand +1,513.0%N/A3.7 $2.57
5/15/202317,700 shares $46.20 thousand -31.4%N/A0.5 $2.61
4/30/202325,800 shares $61.92 thousand +27.1%N/A0.7 $2.40
4/15/202320,300 shares $48.52 thousand +178.1%N/A0.6 $2.39
3/31/20237,300 shares $14.67 thousand -29.1%N/A0.2 $2.01
3/15/202310,300 shares $21.01 thousand -32.2%N/A0.3 $2.04
2/28/202315,200 shares $36.18 thousand +22.6%N/A0.5 $2.38
2/15/202312,400 shares $30.26 thousand +21.6%N/A0.4 $2.44
1/31/202310,200 shares $29.07 thousand -21.5%N/A0.3 $2.85
1/15/202313,000 shares $36.01 thousand -29.7%N/A0.2 $2.77
12/30/202218,500 shares $58.09 thousand +44.5%N/A0.3 $3.14
12/15/202212,800 shares $34.94 thousand -41.6%N/A0.2 $2.73
11/30/202221,900 shares $76.87 thousand +0.5%N/A0.3 $3.51
11/15/202221,800 shares $85.02 thousand No ChangeN/A0.3 $3.90
10/31/202221,800 shares $102.24 thousand -27.6%N/A0.3 $4.69
10/15/202230,100 shares $144.48 thousand -16.4%N/A0.9 $4.80
9/30/202236,000 shares $180.36 thousand -45.4%N/A1 $5.01
9/15/202265,900 shares $392.76 thousand -25.5%N/A1.6 $5.96
8/31/202288,400 shares $511.84 thousand -18.8%N/A1.4 $5.79
8/15/2022108,800 shares $683.26 thousand -22.6%N/A1.6 $6.28
7/31/2022140,600 shares $912.49 thousand -44.2%N/A1.9 $6.49
7/15/2022252,000 shares $1.43 million -17.5%N/A2.7 $5.69
6/30/2022305,300 shares $1.72 million +13.6%N/A1.2 $5.65
Uncle Sam now owns 9.9% of Intel (Ad)

On August 22, 2025, the U.S. government became one of Intel's largest shareholders - converting CHIPS Act grants into a 9.9% equity stake worth 8.9 billion dollars at 20.47 per share. Weeks earlier, the DoD took a 15% stake in rare-earth miner MP Materials, and the DOE followed with a 5% stake in Lithium Americas alongside a 2.23 billion dollar loan. Federal equity ownership in semiconductors, rare earths, and lithium - at this scale - hasn't happened since World War II. Porter Stansberry says the rules of investing are changing, and the stocks positioned to win this realignment aren't the ones the financial press is covering.tc pixel

Watch the full documentary to see which stocks to buy and sell now
6/15/2022268,700 shares $1.35 million -38.5%N/A1 $5.02
5/31/2022437,000 shares $2.34 million +5.1%N/A1.9 $5.35
5/15/2022415,800 shares $2.03 million +10.7%N/A1.8 $4.88
4/30/2022375,600 shares $2.12 million +50.0%N/A1.7 $5.65
4/15/2022250,400 shares $1.88 million +224.4%3.9%1.2 $7.51
3/31/202277,200 shares $310.34 thousand +19.0%0.9%0.5 $4.02
3/15/202264,900 shares $262.85 thousand -44.8%0.7%1.5 $4.05
2/28/2022117,500 shares $572.23 thousand +36.3%1.2%2.4 $4.87
2/15/202286,200 shares $387.90 thousand +9.1%0.9%1.6 $4.50
1/31/202279,000 shares $323.11 thousand +5.6%0.8%1.3 $4.09
1/15/202274,800 shares $295.46 thousand +4.0%0.8%1.2 $3.95
12/31/202171,900 shares $313.48 thousand -5.8%0.8%1.2 $4.36
12/15/202176,300 shares $334.19 thousand -1.0%0.8%1.4 $4.38
11/30/202177,100 shares $431.76 thousand +2.5%0.8%1.4 $5.60
11/15/202175,200 shares $539.94 thousand -51.4%0.9%1.5 $7.18
10/29/2021154,600 shares $1.13 million -3.6%1.8%3.3 $7.30
10/15/2021160,400 shares $1.26 million -20.9%1.9%3.4 $7.85
9/30/2021202,700 shares $1.85 million -0.3%2.3%4.2 $9.12
9/15/2021203,300 shares $1.68 million -3.1%2.4%2.9 $8.28
8/31/2021209,700 shares $1.50 million -11.0%2.4%2.5 $7.14
8/13/2021235,700 shares $1.64 million +1.3%2.7%2.1 $6.94
7/30/2021232,700 shares $1.50 million -2.8%2.7%1.9 $6.44
7/15/2021239,400 shares $1.78 million +0.3%2.8%1.9 $7.45
6/30/2021238,700 shares $1.92 million -43.6%2.8%1.8 $8.03
6/15/2021423,100 shares $3.88 million +17.9%4.9%3.6 $9.17

LYRA Short Interest - Frequently Asked Questions

Short interest is the volume of Lyra Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 13th, investors have sold 42,622 shares of LYRA short. 2.48% of Lyra Therapeutics' shares are currently sold short. Learn More on Lyra Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYRA shares currently have a short interest ratio of 0.5. Learn More on Lyra Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.48% of Lyra Therapeutics' floating shares are currently sold short.

Lyra Therapeutics saw a increase in short interest in March. As of March 13th, there was short interest totaling 42,622 shares, an increase of 157.8% from the previous total of 16,533 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

2.48% of Lyra Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Lyra Therapeutics: Itonic Holdings Ltd. (1.16%), GlucoTrack, Inc. (5.94%), Zynex Inc. (23.48%), Biotricity, Inc. (0.53%), Aethlon Medical, Inc. (21.20%), INVO Fertility, Inc (5.20%), Autonomix Medical, Inc. (9.97%), Valion Bio, Inc. Common Stock (4.79%), Bone Biologics Corp. (0.28%), Bluejay Diagnostics, Inc. (3.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($78.05 billion), Invesco QQQ ($34.95 billion), iShares Russell 2000 ETF ($25.01 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($11.90 billion), iShares 20+ Year Treasury Bond ETF ($10.45 billion), SPDR S&P Biotech ETF ($9.35 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.53 billion), Western Digital Corporation ($7.51 billion), Financial Select Sector SPDR Fund ($7.38 billion), and Lumentum Holdings Inc. ($7.15 billion). View all of the most shorted stocks.

Short selling LYRA is an investing strategy that aims to generate trading profit from Lyra Therapeutics as its price is falling. LYRA shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lyra Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LYRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYRA, twice per month. The most recent reporting period available is March, 13 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LYRA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:LYRA) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
Your name isn't on our protected list yet
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...
American Alternative | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel